CompletedNot Applicable

St. Vincent's Screening To Prevent Heart Failure Study

Ireland1,378 participantsStarted 2005-01

Plain-language summary

The STOP-HF study is a prospective, randomized, controlled trial recruiting asymptomatic individuals with risk factors for left ventricular dysfunction from 50 primary care clinics in Dublin and south east Ireland. It is designed to determine whether using natriuretic peptide measurement as a screening tool following a general cardiovascular risk factor screen will reduce the prevalence and severity of ventricular dysfunction in conjunction with specialist follow-up at St. Vincent's University Hospital.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ≥40 Years of age * with risk factors for LVD including: * hypertension (medicated for ≥ 1 month) * hypercholesterolemia * obesity * coronary artery disease (confirmed by angiography) * diabetes mellitus * arrhythmia * valvular abnormalities Exclusion Criteria: * failure or unwilling to provide informed consent * known ventricular dysfunction (confirmed by angiography or echocardiography) * previous documented episode of heart failure

What they're measuring

Prevalence and severity of LVD

Timeframe: 5 year

Trial details

NCT IDNCT00921960

SponsorSt Vincent's University Hospital, Ireland

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-12

View on ClinicalTrials.gov More Left Ventricular Dysfunction trials